Latin America Nucleotide Market Size & Outlook, 2030

Revenue, 2023 (US$M)

$80.3

Forecast, 2030 (US$M)

$132.8

CAGR, 2024 - 2030

7.5%

Report Coverage

Latin America

Latin America nucleotide market, 2018-2030 (US$M)

Related Markets

Global Nucleotide Industry Outlook

North America Nucleotide Market Outlook

Europe Nucleotide Market Outlook

Asia Pacific Nucleotide Market Outlook

MEA Nucleotide Market Outlook

Latin America nucleotide market highlights

The Latin America nucleotide market generated a revenue of USD 80.3 million in 2023.
The market is expected to grow at a CAGR of 7.5% from 2024 to 2030.
In terms of segment, deoxy nucleotides was the largest revenue generating product in 2023.
Deoxy Nucleotides is the most lucrative product segment registering the fastest growth during the forecast period.

Latin America data book summary

Market revenue in 2023	USD 80.3 million
Market revenue in 2030	USD 132.8 million
Growth rate	7.5% (CAGR from 2023 to 2030)
Largest segment	Deoxy nucleotides
Fastest growing segment	Deoxy Nucleotides
Historical data covered	2018 - 2022
Base year for estimation	2023
Forecast period covered	2024 - 2030
Quantitative units	Revenue in USD million
Market segmentation	Deoxy Nucleotides
Key market players worldwide	Thermo Fisher Scientific Inc, Roche, Biorigin, DSM, Promega, Agilent Technologies Inc, ABF Ingredients

Other key industry trends

In terms of revenue, Latin America region accounted for 9.4% of the global nucleotide market in 2023.
Globally, North America is projected to lead the regional market in terms of revenue in 2030.
Asia Pacific is the fastest growing regional market and is projected to reach USD 328.8 million by 2030.

No credit card required*

Horizon in a snapshot

30K+ Global Market Reports
120K+ Country Reports
1.2M+ Market Statistics
200K+ Company Profiles
Industry insights and more

Nucleotide Market Scope

Nucleotide market segmentation & scope

Product

Deoxy Nucleotides

Dideoxynucleotides

Nucleotides for RNA Synthesis (rNTP)

Labelled Nucleotides

Application

Pharmaceuticals

Diagnostics research

Food & beverage additive

Animal feed additive

Others

Technology

TaqMan allelic discrimination

Gene chips & microarrays

SNP by pyrosequencing

Others

Regions

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Countries

U.S.

Canada

Germany

France

Italy

Spain

Denmark

Sweden

Norway

Japan

China

India

Australia

South Korea

Thailand

Mexico

Brazil

South Africa

Saudi Arabia

Argentina

UAE

Kuwait

Nucleotide Market Companies

Name	Profile	# Employees	HQ	Website

Latin America nucleotide market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nucleotide market will help companies and investors design strategic landscapes.

Deoxy nucleotides was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Latin America nucleotide market based on deoxy nucleotides covering the revenue growth of each sub-segment from 2018 to 2030.

Rising population coupled with an unhealthy diet routine and stressful lifestyle has raised the number of patients suffering from chronical, cardiology and neurodegenerative diseases like blood disorders, cholesterol, Parkinson's disease, Alzheimer's diseases in the region.

This surge has increased the application scope for the genetic technologies including TaqMan allelic discrimination, SNP by pyrosequencing, TaqMan SNP genotyping to understand the mechanisms of disease and predict an individual's risk of developing certain diseases.

The Central & South America is anticipated to witness a significant growth outlook for the nucleotide market over the forecast period on account of the growing consumer food safety, biological concern, animal welfare and other socio-economic factors.

Reasons to subscribe to Latin America nucleotide market databook:

Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Latin America nucleotide market databook

Our clientele includes a mix of nucleotide market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America nucleotide market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America nucleotide market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list